felin
infecti
periton
viru
fipv
caus
fatal
diseas
call
fip
felida
effus
bodi
caviti
commonli
associ
fip
howev
exact
mechan
accumul
effus
remain
unclear
investig
vascular
endotheli
growth
factor
vegf
examin
relationship
vegf
level
amount
effus
cat
fip
furthermor
examin
vegf
product
fipvinfect
monocytesmacrophag
use
felin
vascular
endotheli
cell
examin
vascular
permeabl
induc
cultur
supernat
fipvinfect
macrophag
cat
fip
product
effus
relat
increas
plasma
vegf
level
fipvinfect
monocytesmacrophag
product
vegf
associ
prolifer
viru
furthermor
cultur
supernat
fipvinfect
macrophag
induc
hyperperm
felin
vascular
endotheli
cell
suggest
vascular
permeabl
factor
includ
vegf
produc
fipvinfect
monocytesmacrophag
might
increas
vascular
permeabl
amount
effus
cat
fip
felin
infecti
periton
viru
fipv
felin
coronaviru
fcov
famili
coronavirida
caus
fatal
diseas
call
fip
wild
domest
cat
speci
fcov
mainli
compos
nucleocapsid
n
protein
envelop
protein
membran
protein
peplom
spike
protein
pedersen
fcov
classifi
serotyp
ii
accord
amino
acid
sequenc
protein
motokawa
et
al
motokawa
et
al
serotyp
consist
two
biotyp
fipv
felin
enter
coronaviru
fecv
fecv
infect
asymptomat
cat
contrast
fipv
infect
caus
fip
stoddart
scott
report
prolifer
macrophag
associ
virul
fipv
fecv
exhibit
lower
prolifer
macrophag
fipv
propos
fipv
aris
fecv
mutat
chang
et
al
poland
et
al
vennema
et
al
exact
mutat
induc
factor
yet
clarifi
recent
brown
et
al
theoret
demonstr
fip
develop
via
horizont
infect
fipv
basi
theori
fipv
fecv
preval
among
cat
macrophagesmonocyt
play
import
role
pathogenesi
fip
report
viru
replic
monocytesmacrophag
induc
interleukin
il
tumor
necrosi
factor
tnf
product
regan
et
al
takano
et
al
takano
et
al
fipv
replic
cytokin
product
enhanc
monocytesmacrophag
inocul
fipv
presenc
antifipv
antibodi
antibodydepend
enhanc
ade
hohdatsu
et
al
corapi
et
al
olsen
et
al
phenomenon
ade
involv
aggrav
fip
patholog
pedersen
boyl
takano
et
al
takano
et
al
takano
et
al
fip
character
granulomat
lesion
sever
organ
effus
pleural
periton
caviti
pedersen
suggest
gcsf
gmcsf
produc
fipvinfect
monocytesmacrophag
involv
format
granulomat
lesion
takano
et
al
hand
effus
consid
result
increas
vascular
permeabl
induc
typeiii
hypersensit
reaction
assum
immun
complexmedi
damag
vessel
caus
increas
permeabl
endotheli
cell
cat
fip
weiss
scott
b
howev
report
immun
complex
vascular
lesion
cat
fip
kipar
et
al
specif
factor
typeiii
hypersensit
reaction
may
also
caus
effus
cat
fip
report
vascular
endotheli
growth
factor
vegf
increas
blood
system
vascul
granulomat
lesion
bragado
et
al
li
et
al
maeno
et
al
viac
et
al
vegf
potent
factor
involv
vascular
permeabl
angiogenesi
dvorak
et
al
vegfproduc
cell
includ
monocyt
macrophag
fibroblast
keratinocyt
report
vegf
involv
effus
bodi
caviti
exampl
plasma
leakag
dengu
hemorrhag
fever
ascet
fluid
accumul
ovarian
cancer
kraft
et
al
tseng
et
al
base
find
vegf
may
also
increas
cat
fip
howev
unknown
whether
vegf
involv
effus
cat
fip
determin
plasma
vegf
level
cat
fip
investig
relationship
amount
effus
bodi
caviti
addit
examin
relationship
viral
prolifer
vegf
product
fipvinfect
monocyt
macrophag
furthermor
use
felin
vascular
endotheli
cell
examin
vascular
permeabl
induc
cultur
supernat
fipvinfect
macrophag
compar
level
vegf
plasma
spf
cat
cat
fip
vegf
level
significantli
higher
plasma
cat
fip
spf
cat
fig
cat
fip
amount
effus
per
weight
posit
correl
plasma
vegf
level
fig
timedepend
chang
plasma
vegf
level
fipvinfect
cat
investig
chang
note
plasma
vegf
level
cat
develop
fip
symptom
fipvinfect
nonfip
cat
fipv
infect
experi
complet
day
fipv
infect
fig
cat
cat
fip
plasma
vegf
level
increas
fipv
infect
fig
cat
addit
cat
persist
produc
vegf
fipv
infect
fip
develop
amount
effus
per
weight
tend
increas
fig
b
cat
cat
cat
cat
compar
level
vegf
mrna
fcov
n
gene
express
monocyt
alveolar
macrophag
deriv
spf
cat
cat
fip
vegf
mrna
fcov
n
gene
express
level
increas
monocyt
alveolar
macrophag
deriv
cat
fip
fig
investig
relationship
fipv
infect
vegf
product
monocyt
alveolar
macrophag
spf
catderiv
monocyt
alveolar
macrophag
inocul
medium
alon
viru
alon
mab
alon
mixtur
fipv
mab
day
cultur
supernat
cell
collect
fipv
replic
vegf
product
measur
viru
titer
vegf
product
significantli
higher
cultur
supernat
monocyt
alveolar
macrophag
inocul
mixtur
fipv
mab
monocyt
alveolar
macrophag
cultur
medium
alon
viru
alon
mab
alon
fig
intracellular
fcov
gene
vegf
mrna
express
level
significantli
increas
monocyt
alveolar
macrophag
inocul
mixtur
fipv
mab
fig
show
vegf
product
increas
viru
replic
monocyt
alveolar
macrophag
vascular
endotheli
cell
collect
vessel
spf
cat
see
section
incorpor
effici
dillabel
acetyl
lowdens
lipoprotein
dilacldl
characterist
function
endotheli
cell
compar
crfk
cell
nonvascular
endotheli
cell
human
umbil
vein
endotheli
cell
huvec
human
vascular
endotheli
cell
cell
collect
vessel
spf
cat
show
epitheli
celllik
morpholog
incorpor
dilacldl
fig
similar
result
observ
felin
endotheli
cell
huvec
crfk
cell
show
dilacldl
incorpor
presenc
permeabl
factor
fipvinfect
macrophag
cultur
supernat
investig
felin
vascular
endotheli
cell
expos
h
recombin
felin
vegf
rfvegf
cultur
supernat
macrophag
inocul
mixtur
fipv
mab
cultur
supernat
heat
c
inactiv
virus
control
alveolar
macrophag
cultur
heatinactiv
cultur
super
natant
uninfect
macrophag
endotheli
permeabl
increas
rfvegf
cultur
supernat
macrophag
inocul
mixtur
fipv
mab
compar
cell
cultur
control
supernat
fig
particularli
felin
vascular
endotheli
cell
expos
cultur
supernat
macrophag
inocul
mixtur
fipv
mab
show
markedli
increas
endotheli
permeabl
vegf
major
factor
vascular
permeabl
report
potenc
vegf
vascular
permeabl
time
stronger
histamin
dvorak
et
al
patient
inflammatori
diseas
cancer
product
effus
bodi
caviti
relat
increas
plasma
vegf
level
vascular
permeabl
exampl
patient
rheumatoid
arthriti
amount
synovi
fluid
relat
plasma
vegf
level
fava
et
al
addit
demonstr
vegf
involv
ascit
patient
ovarian
cancer
hu
et
al
mesiano
et
al
studi
observ
significantli
increas
plasma
vegf
level
cat
fip
also
demonstr
correl
plasma
vegf
level
amount
effus
cat
fip
specif
strongli
suggest
vegf
involv
effus
cat
fip
investig
fipvinfect
monocytesmacrophag
vegfproduc
cell
cat
fip
fipvinfect
monocytesmacrophag
major
compon
cell
produc
cytokin
etc
involv
patholog
deterior
regan
et
al
takano
et
al
takano
et
al
demonstr
product
vegf
associ
fipv
prolifer
monocytesmacrophag
mechan
fipvinduc
vegf
product
unknown
regan
et
al
report
fipv
activ
kinas
induc
product
fipvinfect
monocyt
addit
activ
induc
vegf
product
yoshino
et
al
futur
relationship
activ
prolifer
fipv
monocytesmacrophag
examin
demonstr
vascular
permeabilityassoci
factor
exist
cultur
supernat
fipvinfect
macrophag
factor
thermost
report
vegf
thermost
clauss
et
al
base
fact
vegf
may
vascular
permeabilityassoci
factor
exist
cultur
supernat
fipvinfect
macrophag
verifi
concept
examin
whether
antifelin
vegf
antibodi
inhibit
permeabl
felin
vascular
endotheli
cell
induc
cultur
supernat
fipvinfect
macrophag
howev
best
knowledg
antibodi
neutral
felin
vegf
activ
creat
monoclon
antibodi
neutral
felin
vegf
examin
whether
antibodi
inhibit
vascular
permeabl
induc
cultur
supernat
fipvinfect
macrophag
cultur
supernat
fipvinfect
macrophag
contain
vegf
smaller
amount
pgml
vegf
rfvegf
pgml
howev
show
increas
vascular
permeabl
thu
cultur
supernat
fipvinfect
macrophag
contain
vascular
permeabl
factor
vegf
accord
recent
report
increas
vascular
permeabl
induc
vegf
stathopoulo
et
al
like
vegf
thermost
takano
et
al
also
examin
whether
like
vegf
involv
vascular
permeabl
induc
cultur
supernat
fipvinfect
macrophag
cat
volum
effus
low
spite
plasma
vegf
level
high
cat
immedi
sacrif
human
viewpoint
dyspnea
associ
pneumonia
autopsi
cat
slight
effus
present
thorac
abdomin
region
pneumonia
develop
cat
effus
fluid
may
accumul
observ
cat
balanc
helper
th
cat
fipv
infect
critic
examin
whether
fipvinfect
cat
develop
fip
induct
interferon
ifn
cytokin
inhibit
fip
develop
contrast
cytokin
promot
fip
devel
opment
gelain
et
al
goitsuka
et
al
gunnmoor
et
al
kiss
et
al
takano
et
al
interestingli
vegf
product
inhibit
increas
wen
et
al
feurino
et
al
studi
plasma
vegf
level
increas
cat
develop
fip
contrast
plasma
vegf
level
increas
cat
develop
fip
base
find
plasma
vegf
level
may
reflect
immun
statu
fipvinfect
cat
vegf
reportedli
involv
increas
vascular
permeabl
orf
viru
hantaviru
well
fipv
lyttl
et
al
gavrilovskaya
et
al
demonstr
orf
viru
carri
gene
encod
vegf
homolog
vegf
produc
viru
increas
permeabl
vascular
endotheli
cell
lyttl
et
al
gene
encod
vegflik
protein
could
found
fipv
viral
genom
data
shown
specif
unlik
orf
viru
fipv
may
produc
vegf
hand
hantaviru
reportedli
show
increas
suscept
vegf
increas
vascular
permeabl
virusinfect
vascular
endotheli
cell
gavrilovskaya
et
al
unknown
whether
fipv
infect
vascular
endotheli
cell
report
publish
fipv
antigen
detect
vascular
endotheli
cell
cat
fip
howev
demonstr
fipv
prolifer
vascular
endotheli
cell
hightit
fipv
strain
inocul
takano
hohdatsu
unpublish
data
effect
fipv
infect
vascular
endotheli
cell
investig
futur
fip
character
vascul
hayashi
et
al
pedersen
elucid
patholog
fip
desir
conduct
experi
use
felin
vascular
endotheli
cell
howev
report
publish
use
felin
vascular
endotheli
cell
fip
research
one
reason
felin
vascular
endotheli
cell
line
avail
addit
experienc
studi
method
isol
vascular
endotheli
cell
spf
cat
requir
mani
cat
skill
even
cell
success
isol
use
experi
limit
number
passag
felin
vascular
endotheli
cell
line
establish
allow
easi
handl
cell
may
facilit
elucid
mechan
patholog
deterior
fip
diseas
type
fip
divid
wet
effus
dri
noneffus
form
base
presenc
effus
pedersen
cat
fip
experiment
gener
show
variou
diseas
type
cat
show
typic
wetform
fip
other
show
form
pyogranulomat
lesion
variou
organ
accompani
effus
bodi
caviti
howev
dryform
fip
note
reason
unknown
futur
relationship
plasma
vegf
level
investig
use
dryform
fip
type
ii
fipv
strain
tcid
ml
administ
oral
spf
cat
cat
develop
fip
symptom
cat
fip
fever
weight
loss
periton
pleural
effus
dyspnea
ocular
lesion
neural
symptom
use
studi
fip
diagnos
confirm
upon
postmortem
examin
reveal
periton
pleural
effus
pyogranuloma
major
organ
agematch
spf
cat
use
control
protocol
experi
present
studi
use
cat
approv
ethic
committe
kitasato
univers
school
veterinari
medicin
blood
collect
cat
use
heparin
syring
centrifug
rpm
min
supernat
use
plasma
sampl
plasma
sampl
store
c
day
analysi
plasma
concentr
vegf
determin
human
vegf
elisa
kit
r
system
uk
accord
manufactur
protocol
elisa
kit
detect
primarili
felin
vegf
isoform
koga
et
al
feli
catu
whole
cell
grown
eagl
minimum
essenti
medium
contain
medium
fetal
calf
serum
fc
uml
penicillin
gml
streptomycin
felin
monocyt
alveolar
macrophag
maintain
rpmi
growth
medium
supplement
fc
uml
penicillin
gml
streptomycin
felin
vascular
endotheli
cell
huvec
cell
system
usa
cultur
endotheli
growth
medium
cell
system
usa
contain
fc
defin
cell
boost
recombin
growth
factor
cell
system
usa
uml
penicillin
gml
streptomycin
type
ii
fipv
strain
grown
cell
c
fipv
strain
suppli
dr
c
horzinek
state
univers
utrecht
netherland
felin
monocyt
isol
spf
cat
previous
describ
dewerchin
et
al
felin
alveolar
macrophag
obtain
bronchoalveolar
lavag
hank
balanc
salt
solut
hbss
antifcov
antibodyneg
spf
cat
previous
describ
hohdatsu
et
al
felin
vascular
endotheli
cell
obtain
felin
aorta
spf
cat
modifi
method
base
report
describ
ryan
aorta
rins
three
time
hbss
treatment
collagenas
ii
wako
japan
intim
surfac
lightli
scrape
steril
scalpel
blade
scrape
cell
wash
twice
place
collagenco
plastic
plate
three
day
supernat
remov
replac
fresh
medium
cell
becam
confluent
wash
twice
place
collagenco
cm
cultur
flask
endotheli
specif
cell
verifi
uptak
dilacldl
invitrogen
usa
mab
use
present
studi
recogn
protein
type
ii
fipv
demonstr
immunoblot
report
mab
exhibit
neutral
activ
crfk
cell
enhanc
activ
felin
macrophag
depend
reaction
condit
hohdatsu
et
al
rna
isol
cdna
prepar
perform
employ
method
takano
et
al
determin
level
felin
gapdh
mrna
vegf
mrna
fcov
n
gene
express
cdna
amplifi
pcr
use
specif
primer
felin
gapdh
mrna
vegf
mrna
fcov
n
gene
primer
sequenc
shown
tabl
pcr
perform
use
method
takano
et
al
band
densiti
quantifi
appropri
uv
exposur
video
densitometri
use
scion
imag
softwar
scion
corpor
usa
vegf
mrna
fcov
n
gene
quantit
analyz
term
rel
densiti
valu
mrna
housekeep
gene
gapdh
viral
suspens
fipv
strain
tcid
ml
mab
solut
mix
equival
volum
ratio
react
c
h
ml
reaction
solut
use
inocul
alveolar
macrophag
cell
felin
monocyt
cell
cultur
well
multipl
control
medium
alon
viru
suspens
alon
ad
felin
alveolar
macrophag
viru
adsorpt
c
h
cell
wash
hbss
ml
growth
medium
cell
cultur
supernat
collect
h
cell
use
measur
vegf
mrna
fcov
n
gene
cultur
supernat
employ
quantit
analysi
vegf
viru
titer
felin
vascular
endotheli
cell
cell
seed
collagenco
transwel
filter
pore
size
costar
usa
plate
cultur
l
cultur
medium
upper
chamber
l
growth
medium
lower
chamber
cell
becam
confluent
h
seed
incub
supernat
mockinocul
monocytesmacrophag
dilut
supernat
fipvand
mab
monocytesmacrophag
dilut
rfvegf
final
concentr
pgml
r
system
uk
medium
without
supernat
rfvegf
control
h
incub
medium
chamber
remov
l
fitcdextran
final
concentr
mgml
ad
upper
chamber
l
medium
ad
lower
chamber
h
medium
lower
chamber
remov
amount
fitcdextran
determin
spectrometr
nm
data
rel
permeabl
percentag
indic
condit
treat
medium
without
supernat
rfvegf
defin
describ
chen
et
al
data
twogroup
analyz
student
test
multipl
group
analyz
oneway
anova
fig
appli
determin
statist
signific
use
pearson
correl
coeffici
pvalu
consid
indic
signific
differ
compar
group
